Related Experiment Video
Updated: Aug 25, 2026

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
Published on: September 6, 2016
[Influenza vaccination for elderly patients with neurological disease]
Masahide Kaji1, Aya Watanabe, Hisamichi Aizawa
1Kurume University Medical Center, Department of Neurology.
Abstract:
Elderly people have a high risk for influenza and the existence of central neurological disease is also considered to be a high risk factor for to causing pulmonary complications because of misswallowing. One hundred and forty one elderly patients (60 years or older) were observed. As control 243 cases were also inoculated with one dose of the same vaccine. Thirty-five out of the 243 control received a 2nd dose. After one vaccination the rise of HI titer (percentage of cases with > 40 and GMT) was good enough to be effective in both elderly patients and controls. No significant differences between elderly patients and the control group were observed. Booster effects by 2nd vaccination were not revealed. No serious side effects were noted in all cases throughout the study. In conclusion, influenza vaccine was well treated among the patients with neurological diseases.
More Related Videos
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Arboviral Encephalitis
Influenza
Cryptococcal Meningitis
Encephalitis l: Introduction

